Arch Virol

1. IQBAL H, Ahmad F, Ahmad S, Ahmad I, et al
   Phylogenetic and genome-wide analysis of codon usage reveals geographic and host-specific adaptation in Vaccinia virus.
   Arch Virol. 2026;171:178.
   

   >> Share

   
   

   
   BMJ

2. KASSTAN-DABUSH B, Chantler T, Bedford H
   NHS vaccination strategy is set up to fail without a coherent public health agenda.
   BMJ. 2026;393:s857.
   

   >> Share

   
   
3. IACOBUCCI G
   Malaria vaccine reduces child deaths by 13% in Africa, WHO study reports.
   BMJ. 2026;393:s900.
   

   >> Share

   
   
4. FIELDING S
   FDA blocks publication of studies showing covid and shingles vaccines to be safe.
   BMJ. 2026;393:s896.
   

   >> Share

   
   
5. IACOBUCCI G
   Moderna's mRNA flu vaccine outperforms standard shot, study finds.
   BMJ. 2026;393:s895.
   

   >> Share

   
   

   
   Infect Immun

6. BHATTACHARYYA A, Mantis NJ
   OspA antibodies inhibit the in vitro transmigration of Borrelia burgdorferi.
   Infect Immun. 2026;94:e0012826.
   

   >> Share

   
   

   
   Lancet

7. GAYTHORPE KAM, Li X, Shankar M, Hartner AM, et al
   Quantifying relative health impact across Gavi, the Vaccine Alliance's portfolio in 117 countries at the subregional level: a modelling study.
   Lancet. 2026;407:1941-1952.
   

   >> Share

   
   
8. OSEI I, Wutor BM
   Vaccine impact in Gavi-supported countries: balancing evidence with policy needs.
   Lancet. 2026;407:1895-1897.
   

   >> Share

   
   
9. MCCLOSKEY B, Petersen E, Azhar EI, Zumla A, et al
   Meningococcal B resurgence in the UK: implications for updating global vaccine strategies.
   Lancet. 2026 May 8:S0140-6736(26)00863-9. doi: 10.1016/S0140-6736(26)00863.
   

   >> Share

   
   
10. MWAPASA V, Asante KP, Milligan P, Akech S, et al
    Impact of introducing RTS,S/AS01(E) malaria vaccine on mortality in young children in Ghana, Kenya, and Malawi: an observational evaluation of a cluster-randomised implementation programme.
    Lancet. 2026;407:1796-1808.
    

    >> Share

    
    

    
    Pediatr Infect Dis J

11. MARIN M, Raparti L, Leung J, Oliver SE, et al
    Safety and Immunogenicity of Varicella Vaccination in Children and Adolescents Living With HIV: A Systematic Review.
    Pediatr Infect Dis J. 2026 May 11. doi: 10.1097/INF.0000000000005264.
    

    >> Share

    
    

    
    PLoS Med

12. HYSA A, Opi DH, Waterhouse J, Chishimba S, et al
    Antibody fine specificity correlates with protection from malaria for the RTS,S vaccine in young African children: A post hoc analysis of a phase IIb randomised controlled trial.
    PLoS Med. 2026;23:e1004877.
    

    >> Share

    
    

    
    PLoS One

13. KUSEMERERWA S, Kansiime S, Mutonyi G, Kakande A, et al
    Estimating HIV incidence and assessing associated risk factors among adults: Evidence from the 2018-2022 HIV vaccine preparedness cohort in Masaka, Uganda.
    PLoS One. 2026;21:e0348769.
    

    >> Share

    
    
14. LIU Y, Lu E, Ellingson KD, Hollister J, et al
    Unveiling post-vaccination proteomic signatures in SARS-CoV-2 infection-naive individuals associated with Omicron breakthrough infections.
    PLoS One. 2026;21:e0347602.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

15. GAYTAN MO, Dookie RS, Chakraborty S, Narayana Moorthy A, et al
    Identification of immunostimulatory antigens in Group A Streptococcus-derived vesicles.
    Proc Natl Acad Sci U S A. 2026;123:e2537351123.
    

    >> Share

    
    

    
    Vaccine

16. FONTENOT HB, Liebermann EJ, Thompson EL, Coad S, et al
    Factors associated with intention to obtain HPV vaccination at ages 9-10 among parents with varied prior vaccine decision making experiences and choices.
    Vaccine. 2026;85:128698.
    

    >> Share

    
    
17. OPALEYE OO, Esan DT
    Mobile health strategies to improve HPV vaccination uptake among parents of adolescent girls: a scoping review.
    Vaccine. 2026;85:128701.
    

    >> Share

    
    
18. ANABE D, Ilonen J, Barkoff AM, Terasjarvi JT, et al
    Association of HLA class II haplotypes with antibody concentrations after diphtheria-tetanus acellular pertussis booster vaccination in four age groups of Finnish participants.
    Vaccine. 2026;85:128697.
    

    >> Share

    
    
19. LADOMENOU F, Gkorla E, Matalliotakis M, Moulias E, et al
    Pregnant women's knowledge, perceptions, and intention to receive a future group B Streptococcus (GBS) vaccine: a cross-sectional study.
    Vaccine. 2026;85:128706.
    

    >> Share

    
    
20. SHEN Y, Shahn Z, Robertson MM, Gebo K, et al
    Effect of a third COVID-19 vaccine dose on the incidence of Long COVID among adults who completed a primary vaccine series: a target trial emulation in a community-based cohort.
    Vaccine. 2026;84:128666.
    

    >> Share

    
    
21. THEOTONIO DOS SANTOS LF, Gomes AM, Oliveira DA, Mattos AJC, et al
    HPV vaccine and age of sexual debut of adolescents: A nationwide cross-sectional study.
    Vaccine. 2026;84:128677.
    

    >> Share

    
    
22. LAMBERT D, Luisi N
    Prevalence and correlates of COVID-19 vaccine uptake among sexual and gender minority adolescents in the southern United States.
    Vaccine. 2026;84:128661.
    

    >> Share

    
    
23. DONESANA M, Marseglia A, Laterza L, Caimmi SME, et al
    Safety of supervised hospital vaccination in children at risk of hypersensitivity: A 9-year study.
    Vaccine. 2026;84:128663.
    

    >> Share

    
    
24. YU X, Xie S, Luo Y, Zheng J, et al
    A novel subunit vaccine based on glycoprotein H and glycoprotein L fusion against pseudorabies virus infection.
    Vaccine. 2026;84:128681.
    

    >> Share

    
    
25. ELLINGSON MK, Sudarsanam V, Goddard K, Tomar A, et al
    Impact of standing orders on vaccine uptake: A systematic review.
    Vaccine. 2026;84:128664.
    

    >> Share

    
    
26. POURHASHEM Z, Siasi S, Nourani L, Yousefi H, et al
    Multi-antigen transmission-blocking malaria vaccine elicits Th1-biased antibody responses and SMFA-confirmed oocyst reduction in Anopheles stephensi.
    Vaccine. 2026;84:128683.
    

    >> Share

    
    
27. MISHRA S, Kumar V, Kaur G, Baby BA, et al
    Comparative immunogenicity of monomeric and tetrameric Nipah virus G glycoprotein-based vaccine candidates demonstrate robust antibody responses in both forms.
    Vaccine. 2026;84:128682.
    

    >> Share

    
    
28. LI R, Liukang C, Yang H, Zhang X, et al
    Rational design and sequence optimization of an mRNA-LNP vaccine elicits protective immunity against infectious bronchitis virus in chickens.
    Vaccine. 2026;84:128685.
    

    >> Share

    
    
29. HALFMANN PJ, Duffy A, Wang T, Kawaoka Y, et al
    Evaluating the immunogenicity of clade 2 and clade 3 sarbecovirus spike protein nanoparticle vaccines in Syrian hamsters.
    Vaccine. 2026;84:128653.
    

    >> Share

    
    
30. CORTES-AZUERO O, Vegvari C, Sutcliffe E, Roney E, et al
    Modeling optimal deployment strategies for Nipah vaccines and monoclonal antibodies.
    Vaccine. 2026;84:128688.
    

    >> Share

    
    
31. SREEKANTH S, Lahon A
    Strategies to enhance DNA vaccine efficacy against emerging arboviruses: lessons from ZIKA and Chikungunya viruses.
    Vaccine. 2026;85:128680.
    

    >> Share

    
    
32. MARCATO AJ, Campbell PT, Spirkoska V, Ainslie KEC, et al
    Apples and oranges: Better harmonisation of vaccine trials is needed to inform inclusion in immunisation programs.
    Vaccine. 2026;85:128693.
    

    >> Share

    
    
33. DAGNEW AF, Noble R, Cinar A, Burhan E, et al
    Design and feasibility considerations for a phase 3 efficacy trial of the M72/AS01(E-4) tuberculosis vaccine.
    Vaccine. 2026;85:128690.
    

    >> Share

    
    

    
    Virology

34. ZHANG Y, Liu L, Chen T, Li M, et al
    CD25(+) cell depletion enhances protective immunity of PR8 inactivated influenza vaccine in aged mice.
    Virology. 2026;621:110938.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share